A predominant VNTR cluster of Mycobacterium tuberculosis isolates among. asylum seekers in the Netherlands and Denmark deciphered by whole genome
|
|
- Ashley Johnston
- 6 years ago
- Views:
Transcription
1 JCM Accepted Manuscript Posted Online 22 November 2017 J. Clin. Microbiol. doi: /jcm Copyright 2017 Jajou et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license A predominant VNTR cluster of Mycobacterium tuberculosis isolates among asylum seekers in the Netherlands and Denmark deciphered by whole genome sequencing Rana Jajou 1#, Albert de Neeling 1, Erik Michael Rasmussen 2, Anders Norman 2, Arnout Mulder 1, Rianne van Hunen 1,4, Gerard de Vries 1,4, Walid Haddad 3, Richard Anthony 1, Troels Lillebaek 2, Wim van der Hoek 1, Dick van Soolingen 1, National Institute for Public Health and the Environment, Bilthoven, The Netherlands; 2 International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark; 3 Municipal Health Service, GGD Hart voor Brabant, s-hertogenbosch, The Netherlands; 4 KNCV Tuberculosis Foundation, Den Haag, the Netherlands; 5 Radboud University Medical Center, Department of Medical Microbiology, Nijmegen, The Netherlands # Corresponding author: Rana Jajou, National Tuberculosis Reference Laboratory, Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands. T: rana.jajou@rivm.nl
2 Abstract Background: In many countries, Mycobacterium tuberculosis (Mtb) isolates are routinely subjected to VNTR typing to investigate Mtb transmission. Unexpectedly, cross border clusters have been identified among African refugees in the Netherlands and Denmark, although transmission in these countries was unlikely. Whole genome sequencing (WGS) was applied to analyse in depth transmission and assess the precision of VNTR typing. Methods: WGS was applied to 40 Mtb isolates from refugees in the Netherlands and Denmark, mostly from the Horn of Africa, sharing the exact same VNTR profile. Cluster investigations were undertaken to identify in-country epidemiological links. Results: Combining WGS results of isolates, all members of the CAS/Delhi genotype, from both European countries, an average genetic distance of 80 SNPs (maximum 153 SNPs) was observed. Conversely, the few pairs of isolates with confirmed epidemiological links, except for one pair, had a maximum of 12 SNPs distance. WGS divided this refugee cluster into several sub-clusters of patients from the same country of origin. Conclusion: Although the Mtb cases, mainly originating from African countries, shared the exact same VNTR profile, most were clearly distinguished by WGS. The average genetic distance in this specific VNTR cluster was two times greater than in other VNTR clusters. Thus, identical VNTR profiles did not represent recent and direct Mtb transmission for this group of patients. It appears that either these strains from Africa are genetically extremely conserved or there is ongoing transmission of this genotype among refugees on their long migration routes from Africa to Europe. 39
3 40 41 Keywords: Mycobacterium tuberculosis, asylum seekers, The Netherlands, Denmark, VNTR/ WGS Introduction Tuberculosis (TB) is caused by Mycobacterium tuberculosis (Mtb) and is the leading cause of death worldwide from a single pathogen [1]. The Netherlands is a low incidence country, between 1994 and 2014 the incidence of TB declined from 11.7 to 4.9 cases per inhabitants. However, due to the increasing number of immigrants and asylum seekers from high TB incidence countries, in 2015 the TB incidence increased to 5.1 cases per inhabitants. Of all 867 patients diagnosed in 2015, 625 (72.1%) were born outside the Netherlands, with the majority of TB patients originating from Eritrea, Somalia, and Morocco [2]. The increase in immigrants from higher TB incidence countries is also an important issue in other low incidence European countries. In the Nordic countries for instance, a considerable influx of immigrants has been reported that has contributed significantly to the TB incidence in these countries [3-6]. In Denmark for example, in 2015 the overall TB incidence was 6.3 cases per inhabitants of which 75% was of non-danish origin, 19% of these cases were from the Horn of Africa [7]. DNA fingerprinting of all Mtb isolates has been structurally applied in the Netherlands since 1993 and in Denmark since 1992 to monitor TB transmission and is performed by the (inter) National Tuberculosis Reference Laboratories in both countries. IS6110 restriction fragment length polymorphism (RFLP) typing was the first gold standard in typing and was applied from 1993 to 2008 in the Netherlands and from 1992 to 2006 in Denmark. In 2009, 24-loci variable
4 number tandem repeat (VNTR) typing was introduced in the Netherlands as the new standard, in line with international developments [8], with a retrospective re-typing of all isolates from 2004 to For the isolates typed by both RFLP and VNTR typing, the concordance between both methods was described earlier [9]. In Denmark the switch to VNTR typing took place in 2007, with retrospective re-typing of the isolates from 2003 to The Municipal Health Services (MHSs) in the Netherlands receive information on clustering of DNA fingerprints of Mtb isolates on a weekly basis to guide investigations of epidemiological relations and transmission patterns. In Denmark, investigations based on epidemiological links are not as systematically registered and only limited linkage information is available. Already in 1993, the RFLP pattern associated with cluster number 15 was detected in the northern part of the Netherlands and concerned a 20-year-old patient from Somalia who was assumed to suffer from an endogenous reactivation of a latent infection contracted before arriving in the Netherlands. Over the years, this cluster expanded with at least two new cases per year throughout the Netherlands. The change in typing methodology transformed RFLP cluster 15 into VNTR cluster , which has also been identified in Denmark. In the Netherlands, 45 isolates from the period were assigned to cluster Full concordance between the two DNA fingerprinting methods was found in 14/45 (31%) isolates, meaning these isolates had exactly the most prevalent profile of RFLP cluster 15 and VNTR cluster Another 14/45 (31%) isolates, however, presented with a slightly different VNTR, but the same RFLP pattern 15. The remaining 17/45 (38%) isolates revealed the most common VNTR profile , but slightly different RFLP patterns.
5 As both in the Netherlands and Denmark an unexpected high degree of VNTR clustering among refugees and immigrants occurred, WGS was applied to isolates belonging to the asylum seekers VNTR cluster from both countries. The mainly non-infectious character of the Mtb in asylum seekers from several countries and the low degree of confirmed epidemiological links makes transmission in the Netherlands unlikely, and brings into question the specificity of clustering on the basis of RFLP/VNTR in this specific cluster. Based on two previous studies [5, 10], a similar conclusion was made for the majority of cases in the refugee cluster in Denmark. This suggests that 1) transmission occurred on the migration route, or 2) there is a predominant genotype of Mtb with a high degree of genetic conservation circulating in the countries of origin. In this study, the high resolution of WGS and detailed information on patient characteristics was combined to disclose the confusion in the molecular epidemiology of TB in refugees. If a part of the clustering on basis of VNTR typing in this group of patients is resolved in WGS analysis, recent transmission may be overestimated Methods Patient selection Using the most common VNTR profile of cluster RFLP 15/VNTR (24-loci VNTR pattern in the order of loci VNTR154 - VNTR424 - VNTR577 - VNTR VNTR802 - VNTR960 - VNTR VNTR VNTR VNTR2163b - VNTR VNTR VNTR VNTR VNTR VNTR VNTR VNTR VNTR VNTR VNTR VNTR VNTR VNTR4348: ), twelve of the 205 patient isolates from the Netherlands were selected to obtain variation in country of birth, duration of
6 living in the Netherlands (< 6 versus 6 months), multi-drug resistant TB (MDR-TB) diagnosis, and in epidemiological linkage with another patient in the cluster. Patient characteristics were obtained from the Netherlands Tuberculosis Register (NTR) and information on epidemiological links was obtained from the respective MHS. From Denmark, isolates from 31 patients shared the VNTR profile and were all subjected to WGS. The samples of these patients were collected in the period from 2001 through DNA purification The Mtb isolates from the Netherlands were re-grown in Mycobacteria Growth Indicator Tube (MGIT) tubes from the -70 C freezer stocks, except for the isolates from 2016 that were directly available. DNA was isolated and purified with the QIAamp DNA mini kit method (QIAGEN GmbH, Hilden, Germany). Prior to this, the samples were incubated with lysis buffer and proteinase K to release the DNA [11]. Mtb isolates from Denmark were re-grown in MGIT tubes from the -80 C freezer stocks. One ml was taken from a positive MGIT and centrifuged. DNA was isolated according to a previous study [12] Read mapping and variant calling The isolates from the Netherlands were sequenced on an Illumina HiSEQ2500 sequencer and the isolates from Denmark on an Illumina NextSeq following the Nextera XT protocol according to manufacturer s instructions. Breseq software version was used for mapping the reads
7 to the reference genome H37Rv version 3.0 (GenBank Accession AL or Refseq Accession NC_00962) and for calling SNPs supported by 80% of the mapped reads in regions of minimum five reads coverage. Fastq-files of the isolates from the Netherlands were uploaded to PhyResSe ( for assigning a lineage to each isolate. For the isolates from Denmark, the SNP-barcode system proposed by Coll et al [13] was used to assign the isolates to a lineage. This method detected the G/A SNP at position 1,084,911 in all isolates, which identifies them as lineage 3.1.1, i.e. CAS-Delhi. Called variants were compared to a set of global reference strains belonging to the same lineage (ENA accession no.: ERP001731) Data analysis WGS data analysis was performed in R statistics version 3.2. SNPs annotated as PE/PPE, PGRS, esx, repeat, polyketide, pks, or transposase were excluded during WGS data analysis. Squared Euclidean distance matrices were generated to analyse the genetic distance in SNPs between isolates. A minimum spanning tree was built using Ridom SeqSphere+ software version 4.0 (Ridom GmbH, Münster, Germany) to visualize how isolates from the Netherlands and Denmark were clustered according to WGS using a cut-off of maximum 12 SNPs [14]. All isolates from the Netherlands cultured between January 1, 2016 and December 31, 2016 were subjected to both VNTR typing and WGS. Therefore, it was possible to compare the average genetic distance between isolates in cluster with isolates belonging to other VNTR clusters. The phenotypic resistance profile of the MDR-TB patients was verified on the basis of detected
8 mutations in resistance genes using the PhyResSe pipeline. Phenotypic drug susceptibility testing (DST) was performed on a MGIT 960 system Results Description of the clusters Cluster in the Netherlands comprised of 205 patients in 2016, of which 156 (76.1%) were born in Somalia, 29 (14.1%) in Eritrea /Ethiopia, eight (3.9%) in the Netherlands, two (1%) in Sudan, two (1%) in Burundi, two (1%) in Surinam, one (0.5%) in the Netherlands Antilles, one (0.5%) in Pakistan, one (0.5%) in Zambia, one (0.5%) in Uganda, one (0.5%) in Yemen, and one (0.5%) patient whose origin was not registered (Figure 1). Among those 205 patients, 102 were asylum seekers of which 63.7% (65/102) of them had TB diagnosed within 2.5 years after arriving in the Netherlands. Epidemiological links were confirmed for only 3.9% (8/205) of the cases, two cases were identified by RFLP typing and six by VNTR typing. Fifty-four percent (111/205) of the patients were males. Seventy (34.1%) patients had pulmonary tuberculosis (PTB) only, 33 (16.1%) had a combination of PTB/extra-pulmonary tuberculosis (EPTB), and 102 (49.8%) had EPTB only. Data on DST for first line antibiotics showed that 66.8% (137/205) of the isolates were fully sensitive, fifteen (7.3%) were mono-resistant to isoniazid (INH), four (2%) MDR-TB (i.e. INH and rifampicin [RIF] resistant), two (1%) were mono-resistant to RIF, and for the remaining 47 (22.9%) isolates DST results were missing in the NTR Twelve of the 205 isolates from patients in the Netherlands were included in this study consisting of eight patients from Somalia, three from Eritrea (two of them were
9 epidemiologically linked), and one patient from the Netherlands. Four Somalian patients from 2016 were from one family of which the source case, NL16-10, was suspected to have infected the three family members, NL16-09, NL16-11, and NL16-12 based on MHS data (Table 1). Of the twelve included isolates, two were MDR-TB, two streptomycin (STR) resistant, four susceptible, and for the remaining four isolates DST data was not available in the NTR A cluster with the same VNTR pattern in Denmark comprised of 31 cases, of which three cases were excluded due to low coverage of the sequenced isolates, leaving 28 strains available for inclusion in this study (Table 1). Of these 28 cases, 15 (53.6%) originated from Somalia, nine (32.1%) from Eritrea, two (7.1%) from Denmark, one (3.6%) from Uganda, and one (3.6%) case was of unknown country of origin (Figure 2). One of the two Danish-born cases had Somalian parents. Sixty-four percent (18/28) of the patients were males. Ten (35.7%) patients had PTB only, two (7.1%) had a combination of PTB/EPTB, and 16 (57.1%) patients had EPTB only. Isolates from 26 (92.9%) patients were fully sensitive to all first line antibiotics and the remaining two were RIF resistant, of which one was a MDR-TB isolate with additional resistance to EMB, pyrazinamide (PZA), roxithromycin (ROX), cycloserin (CYA), and capreomycin (CPM) WGS clustering of asylum seekers in the Netherlands and Denmark The genetic distance between the isolates from the Netherlands and Denmark, all belonging to the CAS/Delhi genotype, ranged from SNPs; the degree of genetic conservation was comparable among the isolates from the Netherlands as for the isolates from Denmark. The
10 average genetic distance between all 40 isolates in cluster was 80 SNPs compared to 43 SNPs between isolates in other VNTR clusters in the Netherlands. WGS divided the isolates from cluster into several sub-clusters, where all sub-clusters consisted of patients from the same country of origin, except for sub-cluster D, where a native Danish case, DK15-25, clustered with two patients from Eritrea, DK15-04 and DK16-12 (Figure 3). The six isolates from patients in the Netherlands with a confirmed epidemiological link had a genetic distance of 12 SNPs and formed 2/5 WGS sub-clusters (Figure 3: sub-cluster A and B). The only identified epidemiological link for the cases from Denmark was between DK06-29, father, and DK06-14, son, with a genetic distance of 40 SNPs (Figure 3). The genetic distance between isolates from patients without a confirmed epidemiological link ranged from SNPs, meaning some patients for whom epidemiological links could not be identified were clustered on basis of WGS (Figure 3: sub-cluster C, D, and E). Five isolates from Denmark, DK14-07, DK07-16, DK05-18, DK04-20, and DK14-26, had much longer genetic distances than almost all other isolates in the cluster. DK14-26, a Danish born patient with Somalian parents, and DK04-20 who was Somalian, had a distance of 57 SNPs from each other, but varied by 105 SNPs from all other isolates. A similar situation was observed for DK14-07, originally from Somalia, and DK07-16, the only patient originally from Uganda who were most related to each other, but 90 SNPs distant from all other isolates studied. DK05-18 was 100 SNPs distant from all other included isolates.
11 The genetic distance between the three MDR-TB isolates was maximum 59 SNPs, where NL11-03 from Eritrean origin was more related to the Danish case from Somalian origin than to the MDR-TB case in the Netherlands from Somalian origin (Figure 3) Resistance profiles of MDR-TB patients The two MDR-TB isolates from the Netherlands were both resistant to INH, RIF, and EMB. NL11-03 was additionally resistant to STR and PZA. Mutations in associated resistance genes were identified for all drugs except STR. The MDR-TB isolate from Denmark was resistant to RIF, INH, PZA, EMB, ROX, CYA, and CPM. This isolate had mutations in the resistance-associated rpob S450L, katg S315T, pnca W119R, pnca A-11G, and embb M497R genes (Table 2) Discussion This study showed that a large cluster of Mtb isolates, mostly from asylum seekers, shared the same VNTR profile, but were not identical based on WGS analysis. WGS divided this VNTR cluster into several sub-clusters, where almost all sub-clusters included patients from the same country of origin. Moreover, the average genetic distance in this specific VNTR cluster was twice as large as compared to other VNTR clusters. This supports the findings from epidemiological investigation that transmission did not occur in the destination countries. Refugees originate from countries with wars and hunger/financial crises resulting in sustained migration to European countries. The respective patients share migration routes to Europe including long-term stays in large refugee camps where TB transmission most likely occurred. 231
12 This hypothesis is supported by a recent multi-country cluster investigation on 28 migrant MDR- TB cases in Europe, in which it is suggested that cases were part of a chain of recent transmission that has likely occurred in the country of origin or during the migration route [15]. A similar study was performed in Switzerland, a low TB incidence country like the Netherlands. This study re-analysed VNTR clusters using WGS to assess TB transmission among native and foreign-born TB cases. The outcome of this study was comparable to our results; an overestimation of TB transmission based on VNTR typing compared to WGS, especially among immigrants from high TB incidence countries [16]. Several other findings from this study support our hypotheses. In the Netherlands, 19% of the overall TB cases that were clustered by VNTR typing within a two year interval were found to be epidemiologically linked by MHSs in 2014 [2]. However, in the VNTR cluster described in this study TB nurses interviewing the patients could hardly confirm any epidemiological links between cases. The low degree of confirmed epidemiological links identified by MHSs seems to be logical, as in the majority of cases, only non-transmissible EPTB was observed. Also, the average genetic distance between the isolates in cluster was much higher than in other clusters in the Netherlands, in which the degree of confirmation of epidemiological links is in general higher [17]. Therefore, the benefits of WGS for epidemiological research among asylum seekers is even higher than for regular patients in these low prevalence settings. Screening programs in the Netherlands targeting asylum seekers/immigrants from high TB incidence countries, aim to detect TB disease in these populations. However, these screening programs only focus on active disease and not on migrants latently infected. Also in Denmark, asylum seekers are offered health interviews, and in case of symptoms, additional testing can
13 be performed. It is assumed that most asylum seekers who develop disease after arrival are experiencing an endogenous reactivation rather than a new infection due to recent transmission after arriving in the destination country [3, 18]. Nevertheless, the possibility of transmission in the destination country remains. In WGS sub-cluster D for instance, a native Danish patient clustered with patients from Eritrean origin. No information was available about the potential source of infection of this native Danish patient. Although previous studies suggested that transmission of Mtb from immigrants to the native population is limited [5, 10, 19] [20], it is likely that such transmission did occur, since TB was diagnosed in 2015/2016 for all involved patients. Also among the five native Dutch patients in cluster , for two an epidemiological link was confirmed with a patient from Zambia, and one patient had worked in Africa. For the remaining two native Dutch patients an epidemiological link with another patient in the cluster could not be found. Identifying epidemiological links among immigrants remains a challenge due to cultural/language barriers or there is a reluctance to reveal families/friends real identity or actual travel history. In the six pairs of isolates from patients in the Netherlands that had confirmed epidemiological links, the genetic distance was limited to 12 SNPs. In line with the criteria described by Walker et al [14] to rule in a possible epidemiological link, these cases were correctly clustered by VNTR typing. However, the two epidemiologically linked cases in Denmark were 40 SNPs distant from each other. The pace of genetic turnover may be for unknown reasons higher in this strain. For the other non-linked cases in both countries, a genetic distance was found of up to only 153 SNPs. This is highly remarkable, as this suggests an extremely high degree of genetic conservation in this predominant genotype of Mtb circulating in such a large geographic area.
14 One way to investigate the reason for this high degree of conservation would be to sample Mtb in a representative way from TB patients in both Somalia and Eritrea and possibly other countries, to study the actual population structure of Mtb and the degree of genetic conservation within the countries of origin. Giving the low discriminative power of the current DNA typing methods in Western countries when analysing cases from refugees, this seems a sensible investment that may be supported by larger health organizations such as the WHO or the ECDC. In conclusion, VNTR typing of Mtb isolates from African asylum seekers is misleading. When WGS was applied, several sub-clusters were formed consisting of mainly patients from the same country of origin. Despite the fact that the average genetic distance within this cluster was twice as high compared to other VNTR clusters, the degree of genetic conservation within this diverse study population remains remarkable, suggesting these cases are linked and transmission occurred during the migration route or a highly conserved genotype is circulating in the refugees countries of origin Acknowledgement We would like to thank laboratory technician Pia Kristiansen from the International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark for the excellent laboratory work in Denmark. The Danish part of the study was supported by the Novo Nordisk Foundation (grant number NNF7651) and the Lundbeck Foundation (grant number R ). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
15 References 1. World Health Organization Global tuberculosis report Slump E, Erkens CGM, van Hunen R, Schimmel HJ, van Soolingen D, de Vries G Tuberculose in Nederland Retrieved from f175a9d18d98&type=pdf&disposition=inline. 3. Herrador BRG, Rønnig K, Borgen K, Mannsåker T, Dahle UR Description of the largest cluster of tuberculosis notified in Norway : is the Norwegian tuberculosis control programme serving its purpose for high risk groups? BMC Public Health. 15: Søborg B EPIET report - Summary of work activities Lillebaek T, Andersen AB, Bauer J, Dirksen A, Glismann S, de Haas P, Kok-Jensen A Risk of Mycobacterium tuberculosis transmission in a low-incidence country due to immigration from high-incidence areas. J Clin Microbiol. 39(3): Lillebaek T, Andersen AB, Dirksen, A. Smith, E. and L.T.K.-J. Skovgaard, A, Kok-Jensen A Persistent high incidence of tb in immigrants in a low-incidence country. Emerg Infect Dis. 8(7): Statens Serum Institut Tuberculosis Retrieved from 8. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rüsch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring R, Bifani P, Kurepina N, Kreiswirth B, Sola C, Rastogi N, Vatin V, Gutierrez MC, Fauville M, Niemann S, Skuce R, Kremer K, Locht C, van
16 Soolingen D Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol. 44(12): de Beer JL, van Ingen J, de Vries G, Erkens C, Sebek M, Mulder A, Sloot R, van den Brandt AM, Enaimi M, Kremer K, Supply P, van Soolingen D Comparative study of IS6110 restriction fragment length polymorphism and variable-number tandem-repeat typing of Mycobacterium tuberculosis isolates in the Netherlands, based on a 5-year nationwide survey. J Clin Microbiol. 51(4): Kamper-Jørgensen Z, Andersen AB, Kok-Jensen A, Kamper-Jørgensen M, Bygbjerg C, Andersen PH, Thomsen VØ, Lillebaek T Migrant tuberculosis: the extent of transmission in a low burden country. BMC Infect Dis. 12: Qiagen QIAamp DNA mini and blood mini handbook Bjorn-Mortensen K, Zallet J, Lillebaek T, Andersen AB, Niemann S, Rasmussen EM, Kohl TA Direct DNA Extraction from Mycobacterium tuberculosis Frozen Stocks as a Reculture-Independent Approach to Whole-Genome Sequencing. J Clin Microbiol. 53(8): Coll F, McNerney R, Guerra-Assun JA, Glynn JR, Perdigão J, Viveiros M, Portugal I, Pain A, Martin N, Clark TG A robust SNP barcode for typing Mycobacterium tuberculosis complex strains. Nat Commun. 5: Walker TM, Camilla LC, Harrell RH, Evans JT, Kapatai G, Dedicoat, MJ, Eyre, DW, Wilson DJ, Hawkey PM, Crook DW, Parkhill J, Harris D, Walker S, Bowden R, Philip M, Smith EG,
17 Petoa TEA Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis. 13(2): European Centre for Disease Prevention and Control Multidrug-resistant tuberculosis in migrants, multi-country cluster 12 April Stucki D, Ballif M, Egger M, Furrer H, Altpeter E, Battegay M, Droz S, Bruderer T, Coscolla M, Borrell S, Zürcher K, Janssens JP, Calmy A, Stalder JM, Jaton K, Rieder HL, Pfyffer GE, Siegrist HH, Hoffmann M, Fehr J, Dolina M, Frei R, Schrenzel J, Böttger EC, Gagneux S, Fenner L Standard Genotyping Overestimates Transmission of Mycobacterium tuberculosis among Immigrants in a Low-Incidence Country. J Clin Microbiol. 54(7): Sloot R, Borgdorff MW, de Beer J, van Ingen J, Supply P, van Soolingen D Clustering of tuberculosis cases based on variable-number tandem-repeat typing in relation to the population structure of Mycobacterium tuberculosis in the Netherlands. J Clin Microbiol. 51(7): Pareek M, Greenaway C, Noori T, Munoz J, Zenner D The impact of migration on tuberculosis epidemiology and control in high-income countries: a review. BMC Med. 14: Dahle UR, Eldholm V, Winje BA, Mannsåker T, Heldal, E Impact of immigration on the molecular epidemiology of Mycobacterium tuberculosis in a low-incidence country. Am J Respir Crit Care Med. 176(9):
18 Sandgren A, Schepisi MS, Sotgiu G, Huitric E, Migliori GB, Manissero D, van der Werf M, Girardi E Tuberculosis transmission between foreign- and native-born populations in the EU/EEA: a systematic review. Eur Respir.43(4): Figure 1 Cluster RFLP 15 / VNTR in the Netherlands according to origin Figure 2 Cluster VNTR in Denmark according to origin Figure 3 Minimum spanning tree of 40 M. tuberculosis isolates from asylum seekers in the Netherlands (orange) and Denmark (blue) belonging to the same VNTR cluster. No unknown epidemiological links were allowed. The numbers on the branches indicate the genetic distance in SNPs to the nearest isolate. SNP differences between distant strains cannot be reconstituted by summing the number of SNPs on the branches. The red dotted line represents cases of Somalian origin and the red solid line represents cases of Eritrean origin; the first two digits in the case number indicate the year of TB diagnosis. Sub-clustering on the basis of WGS ( 12 SNPs distance between isolates) is shown in grey. 377
19 Somalia Eritrea/Ethiopia Netherlands Sudan Burundi Surinam Netherlands Antilles Pakistan Zambia Uganda Yemen n.a Somalia Eritrea Uganda Denmark n.a.
20 382
21 Table 1 Characteristics of the 40 included M. tuberculosis patients from the Netherlands and Denmark Patient Gender Age at Year of Country of Epidemiological link with Comments clinical diagnosis birth sample taken NL05-01 M Somalia - 6 months in the Netherlands NL06-02 M Somalia - < 6 months in the Netherlands; RFLP 276 NL11-03 M Eritrea - MDR NL13-04 F Somalia - MDR NL14-05 M Eritrea NL NL14-06 M Eritrea NL NL15-07 M Netherlands - - NL15-08 F Somalia - < 6 months in the Netherlands NL16-09 M Somalia NL NL16-10 F Somalia NL16-09,NL16-11,NL NL16-11 M Somalia NL NL16-12 F Somalia NL
22 DK15-01 M Unknown - - DK16-03 M Eritrea - - DK15-04 M Eritrea - - DK01-05 F Somalia - MDR DK16-06 M Eritrea - - DK14-07 M Somalia - Rifampicin monoresistant DK14-08 F Somalia - - DK03-09 M Somalia - - DK05-11 M Somalia - - DK16-12 M Eritrea - - DK06-14 M Somalia DK DK06-15 F Somalia - - DK07-16 F Uganda - - DK07-17 F Somalia - - DK05-18 F Somalia - - DK05-19 M Eritrea - - DK04-20 M Somalia - - DK09-21 F Somalia - - DK16-22 F Eritrea - - DK15-23 M Somalia - -
23 DK16-24 F Eritrea - - DK15-25 M Denmark - - DK14-26 M Denmark - Somalian-born parents DK16-27 F Eritrea - - DK06-29 M Somalia DK DK06-30 M Somalia - - DK13-31 M Somalia - - DK15-32 M Eritrea Table 2 Comparison of phenotypic drug susceptibility testing and WGS of the three MDR patients RIF INH PZA EMB STR Patient DST rpob varia DST katg vari DST pnca vari DST embb vari DST rpsl/ nt ant ant ant gidb/rr s/tlya NL11-03 R S450L C R S315T G R W119R T R Q497R A R S T C C G NL13-04 R S450L C R S315T G S S S R M306I G S S T C T DK01-05 R S450L C R S315T G R A-11G A R Q497R A S S T C G G
24 RIF=Rifampicin; INH=Isoniazid; PZA=Pyrazinamide; EMB=Ethambutol; STR=Streptomycin; DST=Drug susceptibility testing; R=Resistant; S=Susceptible
Transmission of multidrug-resistant tuberculosis in a low-incidence setting, Switzerland, 2006 to 2012
Research articles Transmission of multidrug-resistant in a low-incidence setting, Switzerland, 2006 to 2012 A Somoskovi (asomoskoevi@imm.uzh.ch) 1, P Helbling 2, V Deggim 1, R Hömke 1, C Ritter 1, E C
More informationEpidemiological studies on tuberculosis control and respiratory viruses Sloot, R.
UvA-DARE (Digital Academic Repository) Epidemiological studies on tuberculosis control and respiratory viruses Sloot, R. Link to publication Citation for published version (APA): Sloot, R. (2015). Epidemiological
More informationMolecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA
Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA January 2016 Summary This report describes the geographical and temporal distribution of multidrug-resistant (MDR) tuberculosis
More informationProgress towards tuberculosis elimination: secular trend, immigration and transmission
Eur Respir J 2010; 36: 339 347 DOI: 10.1183/09031936.00155409 CopyrightßERS 2010 Progress towards tuberculosis elimination: secular trend, immigration and transmission M.W. Borgdorff*,#, S. van den Hof
More informationMolecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA
SURVEILLANCE REPORT Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA March 2017 Summary This report describes the geographical and temporal distribution of multidrug-resistant
More informationMultidrug-resistant Tuberculosis - World, Europe, Switzerland
Multidrug-resistant Tuberculosis - World, Europe, Switzerland Magglingen March 23, 2017 peter.helbling@bag.admin.ch Topics Definitions Epidemiology of TB and MDR-TB worldwide Treatment outcome results
More informationThe incubation period distribution of tuberculosis estimated with a molecular epidemiological approach
Published by Oxford University Press on behalf of the International Epidemiological Association ß The Author 2011; all rights reserved. Advance Access publication 26 March 2011 International Journal of
More informationProgress towards tuberculosis elimination: secular trend, immigration and. transmission
ERJ Express. Published on December 8, 2009 as doi: 10.1183/09031936.00155409 Progress towards tuberculosis elimination: secular trend, immigration and transmission Martien W. Borgdorff [1,2], Susan van
More informationReal-time molecular epidemiology of tuberculosis by direct genotyping. of smear-positive clinical specimens
JCM Accepts, published online ahead of print on 29 February 2012 J. Clin. Microbiol. doi:10.1128/jcm.00132-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Real-time molecular
More informationTransmissibility, virulence and fitness of resistant strains of M. tuberculosis. CHIANG Chen-Yuan MD, MPH, DrPhilos
Transmissibility, virulence and fitness of resistant strains of M. tuberculosis CHIANG Chen-Yuan MD, MPH, DrPhilos Transmissibility, Virulence and Fitness of resistant strains of M. tuberculosis For infectious
More informationMolecular surveillance of multi- and extensively drugresistant tuberculosis transmission in the European Union from 2003 to 2011
Surveillance and outbreak reports Molecular surveillance of multi- and extensively drugresistant tuberculosis transmission in the European Union from 23 to 211 J L De Beer (jessica.de.beer@rivm.nl) 1,
More informationOUT-TB Web. Ontario Universal Typing of Tuberculosis: Surveillance and Communication System
OUT-TB Web Ontario Universal Typing of Tuberculosis: Surveillance and Communication System Dr. Frances Jamieson, Ontario Public Health Laboratories November 30 th, 2009 Tuberculosis : A Global Problem
More informationProgrammatic latent tuberculosis control in the European Union and candidate countries - Draft conclusions
ECDC GUIDANCE Programmatic latent tuberculosis control in the European Union and candidate countries - Draft conclusions Gerard de Vries Dominik Zenner On behalf of the ad hoc scientific panel appointed
More informationGlobal Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics
Global Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics Neel R. Gandhi, MD Emory Rollins School of Public Health January 17, 2013 Medical Research Council BMJ 1948
More informationTuberculosis in Greece: bacteriologically confirmed cases and anti-tuberculosis drug resistance,
Surveillance and outbreak reports Tuberculosis in Greece: bacteriologically confirmed cases and anti-tuberculosis drug resistance, 1995-2009 D Papaventsis (dpapaventsis@yahoo.gr) 1, S Nikolaou 1, S Karabela
More informationMolecular Epidemiology of Tuberculosis. Kathy DeRiemer, PhD, MPH School of Medicine University of California, Davis
Molecular Epidemiology of Tuberculosis Kathy DeRiemer, PhD, MPH School of Medicine University of California, Davis Overview TB transmission and pathogenesis Genotyping methods Genotyping for clinical management
More informationDiagnosis of drug resistant TB
Diagnosis of drug resistant TB Megan Murray, MD, ScD Harvard School of Public Health Brigham and Women s Hospital Harvard Medical School Broad Institute Global burden of TB 9 million new cases year 2 million
More informationTB trends and TB genotyping
Management of a TB Contact Investigation for Public Health Workers Albuquerque, NM October 1, 214 TB trends and TB genotyping Marcos Burgos MD October 1, 214 Marcos Burgos, MD has the following disclosures
More informationHow Is TB Transmitted? Sébastien Gagneux, PhD 20 th March, 2008
How Is TB Transmitted? Sébastien Gagneux, PhD 20 th March, 2008 Today s Outline 1) Global spread of Mtb Comparative genomics Phylogeny 2) Transmission of drug-resistant Mtb Fitness assays Molecular epidemiology
More informationMolecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.
Title Molecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium. Author(s) Ho, PL; Yam, WC; Leung, CC; Yew, WW; Mok, TYW; Chan, KS; Tam, CM Citation Hong Kong Medical
More informationMaha R Farhat, MD MSc Massachusetts General Hospital Harvard Medical School. I have no financial or other potential conflicts of interest to disclose
Maha R Farhat, MD MSc Massachusetts General Hospital Harvard Medical School I have no financial or other potential conflicts of interest to disclose Update on the epidemiology of TB drug resistance Success
More informationRisk of Mycobacterium tuberculosis Transmission in a Low-Incidence Country Due to Immigration from High-Incidence Areas
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 2001, p. 855 861 Vol. 39, No. 3 0095-1137/01/$04.00 0 DOI: 10.1128/JCM.39.3.855 861.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Risk
More informationDrug susceptibility testing for tuberculosis KRISTEN DICKS, MD, MPH DUKE UNIVERSITY MEDICAL CENTER
Drug susceptibility testing for tuberculosis KRISTEN DICKS, MD, MPH DUKE UNIVERSITY MEDICAL CENTER Outline Drug resistant TB: definitions and epidemiology How does TB become resistant? Current drug susceptibility
More informationA ten-year evolution of a multidrugresistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia ( )
A ten-year evolution of a multidrugresistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia (2001-2011) Naira Dekhil 1, Besma Mhenni 1, Raja Haltiti 2, and Helmi Mardassi 1 (speaker)
More informationMultidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area
Rapid communications Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area C Ködmön (csaba.kodmon@ecdc.europa.eu)
More informationMULTIDRUG- RESISTANT TUBERCULOSIS. Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic
MULTIDRUG- RESISTANT TUBERCULOSIS Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic I have no relevant financial relationships. Discussion includes off label use of: amikacin
More informationTB Control in Finland - the role of THL
TB Control in Finland - the role of THL Hanna Soini THL, Department of Health Security 1 TB in Finland 1950-2014 12000 10000 8000 6000 TB ulkomaalaiset TB yhteensä 4000 2000 0 1950 1955 1960 1965 1970
More informationDrug resistance-conferring mutations in Mycobacterium tuberculosis from Madang, Papua New Guinea
Ballif et al. BMC Microbiology 2012, 12:191 RESEARCH ARTICLE Open Access Drug resistance-conferring mutations in Mycobacterium tuberculosis from Madang, Papua New Guinea Marie Ballif 1,2, Paul Harino 3,
More informationQian Gao Fudan University
Qian Gao Fudan University Outline Background & Objectives Genotyping methods Establish the epidemiological field sites Preliminary results of Molecular epidemiology of TB in China Molecular epidemiology
More informationDiagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014
TB Nurse Case Management San Antonio, Texas April 1 3, 2014 Diagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014 Ken Jost, BA has the following disclosures to make: No conflict of interests No relevant
More informationMolecular epidemiology of Mycobacterium tuberculosis in East Lancashire 2001e2009
1 HPA Regional Centre for Mycobacteriology, Newcastle General Hospital, Newcastle upon Tyne, UK 2 Department of Microbiology, Royal Blackburn Hospital, Blackburn, Lancashire, UK 3 Department of Respiratory
More informationMIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex
MIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex Marie Claire Rowlinson, PhD D(ABMM) Florida Bureau of Public Health Laboratories
More informationEpidemiology and diagnosis of MDR-TB in children H Simon Schaaf
Epidemiology and diagnosis of MDR-TB in children H Simon Schaaf Desmond Tutu TB Centre Department of Paediatrics and Child Health, Stellenbosch University, and Tygerberg Children s Hospital (TCH) Definitions
More informationMultidrug resistance (MDR) epitomises. Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan
Eur Respir J 2009; 33: 368 374 DOI: 10.1183/09031936.00089808 CopyrightßERS Journals Ltd 2009 Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan
More informationTuberculosis Genotyping in British Columbia
Tuberculosis Genotyping in British Columbia 10-year Retrospective Study Report Prepared by: Jennifer L. Guthrie, PhD Candidate Email: jennifer.guthrie@alumni.ubc.ca School of Population and Public Health
More informationResearch Article Use of Genotype MTBDRplus Assay for Diagnosis of Multidrug-Resistant Tuberculosis in Nepal
Hindawi International Scholarly Research Notices Volume 2017, Article ID 1635780, 5 pages https://doi.org/10.1155/2017/1635780 Research Article Use of Genotype MTBDRplus Assay for Diagnosis of Multidrug-Resistant
More informationORIGINAL ARTICLE /j x
ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01495.x Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katg: a decade of experience
More informationMDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT
TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives Martie van der Walt IOM Meeting 15-17 January 2013 introduction 1 min 150 words
More informationDNA FINGERPRINTING. Barry N. Kreiswirth, PhD Director, PHRI TB Center
DNA FINGERPRINTING Barry N. Kreiswirth, PhD Director, PHRI TB Center Molecular Epidemiology Local Epidemiology Are M. tuberculosis isolates recovered from localized cases of disease the same or different
More informationMycobacterium tuberculosis and Molecular Epidemiology: An Overview
Journal of Microbiology Research 2014, 4(6A): 25-31 DOI: 10.5923/s.microbiology.201401.04 Mycobacterium tuberculosis and Molecular Epidemiology: An Overview Asho Ali Department of Biology, King Abdul Aziz
More informationThe re-emergence of tuberculosis: what have we learnt from molecular epidemiology?
REVIEW 10.1111/1469-0691.12253 The re-emergence of tuberculosis: what have we learnt from molecular epidemiology? M. W. Borgdorff 1,2 and D. van Soolingen 3,4 1) Department of Infectious Diseases, Public
More informationTuberculosis Transmission by Patients with Smear- Negative Pulmonary Tuberculosis in a Large Cohort in The Netherlands
MAJOR ARTICLE Tuberculosis Transmission by Patients with Smear- Negative Pulmonary Tuberculosis in a Large Cohort in The Netherlands Alma Tostmann, 1,2 Sandra V. Kik, 3,4 Nico A. Kalisvaart, 3 Maruschka
More informationThe authors assessed drug susceptibility patterns
Drug Resistance Among Tuberculosis Patients, 1991 and 1992 New York City, CYNTHIA R. DRIVER, RN, MPH THOMAS R. FRIEDEN, MD, MPH ALAN B. BLOCH, MD, MPH IDA M. ONORATO, MD All the authors are with the Division
More informationPATTERNS OF DRUG RESISTANCE AND RFLP ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS STRAINS ISOLATED FROM RECURRENT TUBERCULOSIS PATIENTS IN SRI LANKA
PATTERNS OF DRUG RESISTANCE AND RFLP ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS STRAINS ISOLATED FROM RECURRENT TUBERCULOSIS PATIENTS IN SRI LANKA DN Magana-Arachchi 1, AJ Perera 1, V Senaratne 2 and NV Chandrasekharan
More informationRisk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands
ORIGINAL ARTICLE TUBERCULOSIS Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands Connie G.M. Erkens 1, Erika Slump 2, Maurits Verhagen
More informationAnnual surveillance report 2015
Annual surveillance report 215 Acknowledgements The Public Health Agency Northern Ireland gratefully acknowledges all those who contributed to this report, including; physicians, nurses, microbiologists,
More informationHepatitis A SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods
SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Hepatitis A Key facts In 2015, 29 EU/EEA countries reported a total of 12 641 cases of hepatitis A, 12 527 (99.1%) of which were confirmed. The
More informationGlobal epidemiology of drug-resistant tuberculosis. Factors contributing to the epidemic of MDR/XDR-TB. CHIANG Chen-Yuan MD, MPH, DrPhilos
Global epidemiology of drug-resistant tuberculosis Factors contributing to the epidemic of MDR/XDR-TB CHIANG Chen-Yuan MD, MPH, DrPhilos By the end of this presentation, participants would be able to describe
More informationGenotypic characteristics of Mycobacterium tuberculosis isolated from household contacts of tuberculosis patients in the Philippines
Sia et al. BMC Infectious Diseases 2013, 13:571 RESEARCH ARTICLE Open Access Genotypic characteristics of Mycobacterium tuberculosis isolated from household contacts of tuberculosis patients in the Philippines
More informationGenotypic characterization and historical perspective of Mycobacterium tuberculosis among older and younger Finns,
ORIGINAL ARTICLE BACTERIOLOGY Genotypic characterization and historical perspective of Mycobacterium tuberculosis among older and younger Finns, 2008 2011 P. W. Smit 1,2, M. Haanper a 2, P. Rantala 2,
More informationMonitoring & evaluation LTBI management in the Netherlands. Key lessons.
Monitoring & evaluation LTBI management in the Netherlands. Key lessons. Gerard de Vries, MD MSc PhD, Coordinator TB control the Netherlands, KNCV Tuberculosis Foundation/RIVM-CIb Global WHO Consultation
More informationAnnual Epidemiological Report
Annual Epidemiological Report March 2018 National TB surveillance in Ireland, 2017 Key Facts 321 TB cases were notified to HPSC corresponding to a crude incidence rate (CIR) of 6.7 HSE East reported the
More informationDST for detection of DR TB - roll out of Xpert in South Africa and overview of other technologies: what are the gaps?
DST for detection of DR TB - roll out of Xpert in South Africa and overview of other technologies: what are the gaps? Mark Nicol Division of Medical Microbiology and Institute for Infectious Diseases and
More informationDiversity of Mycobacterium tuberculosis Isolates in an Immigrant Population: Evidence against a Founder Effect
American Journal of Epidemiology Copyright 2004 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 159, No. 5 Printed in U.S.A. DOI: 10.1093/aje/kwh065 Diversity of Mycobacterium
More informationKen Jost, BA, has the following disclosures to make:
Diagnosis of TB Disease: Laboratory Ken Jost, BA May 10, 2017 TB Intensive May 9-12, 2017 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Ken Jost, BA, has the following disclosures to make: No conflict
More informationTreatment of Active Tuberculosis
Treatment of Active Tuberculosis Jeremy Clain, MD Pulmonary & Critical Care Medicine Mayo Clinic October 16, 2017 2014 MFMER slide-1 Disclosures No relevant financial relationships No conflicts of interest
More informationA review of paediatric tuberculosis in Denmark: ten year trend,
ERJ Express. Published on August 29, 2013 as doi: 10.1183/09031936.00059913 Title: A review of paediatric tuberculosis in Denmark: ten year trend, 2000-2009 Authors: Camilla Hatleberg 1, Julie B. Prahl
More informationJillian Dormandy, BS; Akos Somoskovi, MD, PhD; Barry N. Kreiswirth, PhD; Jeffrey R. Driscoll, PhD; David Ashkin, MD; and Max Salfinger, MD
Original Research LUNG INFECTION Discrepant Results Between Pyrazinamide Susceptibility Testing by the Reference BACTEC 460TB Method and pnca DNA Sequencing in Patients Infected With Multidrug-Resistant
More informationTB BASICS: PRIORITIES AND CLASSIFICATIONS
TB CASE MANAGEMENT AND CONTACT INVESTIGATION INTENSIVE NOVEMBER 1-4, 2016 TB BASICS: PRIORITIES AND CLASSIFICATIONS LEARNING OBJECTIVES Upon completion of this session, participants will be able to: 1.
More information2016 Annual Tuberculosis Report For Fresno County
206 Annual Tuberculosis Report For Fresno County Cases Rate per 00,000 people 206 Tuberculosis Annual Report Fresno County Department of Public Health (FCDPH) Tuberculosis Control Program Tuberculosis
More informationMolecular Epidemiology and Clinical Characteristics of Drug-Resistant Mycobacterium tuberculosis in a Tuberculosis Referral Hospital in China
Molecular Epidemiology and Clinical Characteristics of Drug-Resistant Mycobacterium tuberculosis in a Tuberculosis Referral Hospital in China Qi Wang 1., Susanna K. P. Lau 2., Fei Liu 1., Yanlin Zhao 3,
More informationArizona Annual Tuberculosis Surveillance Report
Arizona Annual Tuberculosis Surveillance Report 2014 Table of Contents I. Executive Summary 1 II. Case Rates 3 III. Cases and Case Rates by Race and Ethnicity 4 IV. Cases by Gender 4 V. Cases and Case
More informationDANISH GUIDELINES FOR PREVENTION AND TREATMENT OF TB IN CHILDREN
DANISH GUIDELINES FOR PREVENTION AND TREATMENT OF TB IN CHILDREN Troels Lillebæk Director, Consultant, DMSc, DTM&H International Reference Laboratory of Mycobacteriology / WHO TB Supranational Reference
More informationMonitoring latent tuberculosis infection diagnosis and management in the Netherlands
ERJ Express. Published on February 25, 2016 as doi: 10.1183/13993003.01397-2015 ORIGINAL ARTICLE IN PRESS CORRECTED PROOF Monitoring latent tuberculosis infection diagnosis and management in the Netherlands
More informationTuberculosis transmission in the Netherlands : the role of immigration and travel Kik, S.V.
UvA-DARE (Digital Academic Repository) Tuberculosis transmission in the Netherlands : the role of immigration and travel Kik, S.V. Link to publication Citation for published version (APA): Kik, S. V. (2009).
More informationAnnual Tuberculosis Report Oregon 2007
Annual Tuberculosis Report Oregon 7 Oregon Department of Human Services Public Health Division TB Program April 8 Page 2 Table of Contents Charts Chart 1 TB Incidence in the US and Oregon, 1985-7.. page
More informationMycobacteria Diagnostic Testing in Manitoba. Dr. Michelle Alfa Medical Director, DSM Clin Micro Discipline
Mycobacteria Diagnostic Testing in Manitoba Dr. Michelle Alfa Medical Director, DSM Clin Micro Discipline Acknowlegements: Assunta Rendina: Charge Tech HSC Lab Joyce Wolf & Dr. Meenu Sharma: NML Dr. Kanchana
More information7. Are you currently engaged in research that could support new TB diagnostic assay development? Yes No
Determining Future TB Reference Material Requirements WHO/TDR TB Expert & End-User Survey Properly handled samples from well-characterized patients with suspected tuberculosis from disease endemic countries
More informationA tale of two settings: the role of the Beijing genotype in the epidemiology of MDR-TB.
ERJ Express. Published on September 13, 2013 as doi: 10.1183/09031936.00140513 A tale of two settings: the role of the Beijing genotype in the epidemiology of MDR-TB. Helen R. Stagg a,b,c, *, Ted Cohen
More informationAnnual surveillance report 2016
Annual surveillance report 216 Acknowledgements The Public Health Agency Northern Ireland gratefully acknowledges all those who contributed to this report, including; physicians, nurses, microbiologists,
More informationA Finer Snapshot of Circulating Mycobacterium tuberculosis Genotypes in Guadeloupe, Martinique, and French Guiana
JCM Accepts, published online ahead of print on May J. Clin. Microbiol. doi:.8/jcm.78- Copyright, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved. 6 7 8 9
More informationMicrobiological Pathology, Sefako Makgatho Health Science University, Pretoria, South Africa 2
The Incidence of discordant Rifampicin susceptibility results between genotypic and phenotypic methods in Mycobacterium tuberculosis complex isolates at Dr George Mukhari Hospital Tertiary Laboratory,
More informationMulti-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis
JCM Accepts, published online ahead of print on 30 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.00678-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Multi-clonal origin
More informationVNTR . VNTR. VNTR. (Original Article) PCR-RFLP ( ETR-B, ETR-C, ETR-D, ETR-E, ETR-F : 7 .VNTR : : (Atypical Mycobacteria)
90 11 3 (Original Article) 4 3 2 1 1. 2. 3. 4. (Non- Tuberculosis Mycobacterium, NTM) :.. (Variable Number Tandem Repeat, VNTR). VNTR ) 48 : PCR-RFLP ( MPTR-A, ETR-A, ETR-B, ETR-C, ETR-D, ETR-E, ETR-F
More informationTB 101 Disease, Clinical Assessment and Lab Testing
TB 101 Disease, Clinical Assessment and Lab Testing Pacific Islands Tuberculosis Controllers Association Conference (PITCA) Clinical Laboratory Breakout None Disclosure Objectives Be able to list and explain
More informationIbrahim Abubakar, MBBS, MSc, PhD, FFPH
Ibrahim Abubakar, MBBS, MSc, PhD, FFPH Head of Section / Consultant Epidemiologist Tuberculosis Section HPA Centre for Infections Colindale London UK Outline TB epidemiological situation UK data collection
More informationThe Epidemiology of Tuberculosis in Minnesota,
The Epidemiology of Tuberculosis in Minnesota, 2011 2015 Minnesota Department of Health Tuberculosis Prevention and Control Program (651) 201-5414 Tuberculosis surveillance data for Minnesota are available
More informationReceived 6 July 2006/Returned for modification 13 October 2006/Accepted 13 December 2006
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 2007, p. 691 697 Vol. 45, No. 3 0095-1137/07/$08.00 0 doi:10.1128/jcm.01393-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. Assessment
More informationCitation for the original published paper (version of record): N.B. When citing this work, cite the original published paper.
http://www.diva-portal.org This is the published version of a paper published in Scientific Reports. Citation for the original published paper (version of record): Alaridah, N., Hallbäck, E T., Tångrot,
More informationDrug Resistant Tuberculosis Biology, Epidemiology and Control Dr. Christopher Dye
Director of Health Information World Health Organization Geneva 1 1. Why TB patients are treated with drugs 2 Natural history and control of TB Fast 5/1 Slow 5/1 Uninfected Latent Active 1 1 infection/case
More informationCalifornia s Experiences Using Tuberculosis Whole Genome Sequencing
California s Experiences Using Tuberculosis Whole Genome Sequencing Martin Cilnis MS, MPH Epidemiologist California Department of Public Health, TB Control Branch, Outbreak Prevention and Control Section
More informationRecognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016
Recognizing MDR-TB in Children Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention 17-18 February 2016 Objectives Review the definitions and categorization of drugresistant tuberculosis Understand the
More informationCalifornia s Experiences Using Tuberculosis Whole Genome Sequencing
California s Experiences Using Tuberculosis Whole Genome Sequencing Martin Cilnis MS, MPH Epidemiologist California Department of Public Health, TB Control Branch, Outbreak Prevention and Control Section
More informationOsaka City is the third largest city (population
Surveillance Report Strengthened tuberculosis control programme and trend of multidrug resistant tuberculosis rate in Osaka City, Japan Akira Shimouchi, a Akihiro Ohkado, a Kenji Matsumoto, b Jun Komukai,
More informationEpidemiology of tuberculosis in Europe. Marieke J. van der Werf European Centre for Disease Prevention and Control Amsterdam, 22 September 2014
Epidemiology of tuberculosis in Europe Marieke J. van der Werf European Centre for Disease Prevention and Control Amsterdam, 22 September 2014 Tuberculosis surveillance in the EU Aim: To provide a complete
More informationUsefulness of Spoligotyping To Discriminate IS6110 Low-Copy- Number Mycobacterium tuberculosis Complex Strains Cultured in Denmark
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1999, p. 2602 2606 Vol. 37, No. 8 0095-1137/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Usefulness of Spoligotyping To Discriminate
More informationTuberculosis Disparity Between US-born African-Americans and Caucasians in Houston:
Tuberculosis Disparity Between US-born African-Americans and Caucasians in Houston: A population-based study Jose A. Serpa 1, M.D.; Larry D. Teeter 2, Ph.D., James M. Musser 2, M.D., Ph.D. and Edward A.
More informationTUBERCULOSIS AND MDR-TB IN THE NORTHERN EMIRATES OF UNITED ARAB EMIRATES: A 5-YEAR STUDY
TUBERCULOSIS AND MDR-TB IN THE UAE TUBERCULOSIS AND MDR-TB IN THE NORTHERN EMIRATES OF UNITED ARAB EMIRATES: A 5-YEAR STUDY Mansour AL-Zarouni 1, Nihar Dash 2, Mahar Al Ali 3, Fatma Al-Shehhi 1 and Debadatta
More informationAuthor s response to reviews Title: Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis
Author s response to reviews Title: Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis Authors: Phan Thai (phanvuongkhacthai@yahoo.com) Dang Ha
More informationNew Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents
New Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents Jeffrey R. Starke, M.D. Professor of Pediatrics Baylor College of Medicine [With great thanks to Andrea
More informationDrug resistance surveillance: progress to date and emerging innovations
Drug resistance surveillance: progress to date and emerging innovations Anna Dean Matteo Zignol WHO Global Task Force on TB Impact Measurement Glion-sur-Montreux 19 21 April 2016 1. Global project on anti-tb
More informationTransmission of MDR/XDR Tuberculosis in Shanghai. Qian Gao Shanghai Medical College Fudan University
Transmission of MDR/XDR Tuberculosis in Shanghai Qian Gao Shanghai Medical College Fudan University Drug Resistant TB in China The Highest DR-TB Burden Country New TB cases/year Cases with any DR MDR XDR
More informationThe epidemiology of tuberculosis
The epidemiology of tuberculosis Tuberculosis Workshop Shanghai, 12-22 May 28 Philippe Glaziou World Health Organization Outline Epidemiology refresher Estimates of tuberculosis disease burden Notifications
More informationExploring the evolution of MRSA with Whole Genome Sequencing
Exploring the evolution of MRSA with Whole Genome Sequencing PhD student: Zheng WANG Supervisor: Professor Margaret IP Department of Microbiology, CUHK Joint Graduate Seminar Department of Microbiology,
More informationTuberculosis in Greenland current situation and future challenges
Tuberculosis in Greenland current situation and future challenges Thomsen VØ 1, Lillebaek T 1, Stenz F 2,*. 1 International Reference Laboratory of Mycobacteriology, Statens Serum Institut (SSI), the National
More informationUNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL THESIS ABSTRACT
UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL THESIS ABSTRACT Epidemiological aspects of tuberculosis disease in disadvantaged population groups in Dolj county in the period 2006-2011 PhD Supervisor,
More informationRapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa
Journal of Antimicrobial Chemotherapy Advance Access published October 21, 2008 Journal of Antimicrobial Chemotherapy doi:10.1093/jac/dkn433 Rapid genotypic assays to identify drug-resistant Mycobacterium
More informationStacy White, PhD May 12, TB for Community Providers. Phoenix, Arizona
Role of the Laboratory in TB Diagnosis Stacy White, PhD May 12, 2015 TB for Community Providers May 12, 2015 Phoenix, Arizona EXCELLENCE EXPERTISE INNOVATION Stacy White, PhD has the following disclosures
More information3.1 PHASE 2 OF THE GLOBAL PROJECT
RESULTS CHAPTER 3 3.1 PHASE 2 OF THE GLOBAL PROJECT (1996 1999) This new report of the Global Project provides data on anti-tuberculosis drug resistance from 58 geographical settings. Of these, 28 provided
More informationThe Molecular Epidemiology of Tuberculosis
The Molecular Epidemiology of Tuberculosis Barry N. Kreiswirth,, PhD Director, PHRI TB Center Airborne pathogen, Mycobacterium tuberculosis Slow grower; doubles 24hrs; 3-4 weeks to culture 3-4 weeks for
More information